Shouyao Holdings (Beijing) Co., LTD. (SHA:688197)

China flag China · Delayed Price · Currency is CNY
40.60
+0.39 (0.97%)
At close: Apr 29, 2026
34.08%
Market Cap 6.04B
Revenue (ttm) 34.67M
Net Income (ttm) -93.17M
Shares Out 148.72M
EPS (ttm) -0.84
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,539,611
Average Volume 1,908,970
Open 40.00
Previous Close 40.21
Day's Range 39.63 - 41.48
52-Week Range 29.46 - 56.86
Beta 0.82
RSI 53.80
Earnings Date Apr 18, 2026

About SHA:688197

Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of innovative drugs in China. The company offers drugs for various indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 172
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688197
Full Company Profile

Financial Performance

In 2025, SHA:688197's revenue was 8.67 million, an increase of 119.88% compared to the previous year's 3.94 million. Losses were -128.83 million, -39.21% less than in 2024.

Financial Statements

News

There is no news available yet.